Esromiotin en es it fr

Esromiotin Brand names, Esromiotin Analogs

Esromiotin Brand Names Mixture

  • No information avaliable

Esromiotin Chemical_Formula


Esromiotin RX_link

Esromiotin fda sheet

Esromiotin msds (material safety sheet)

Esromiotin Synthesis Reference

Zhang J,et al. Appl Microbiol Biotechnol. 44(5):568-75.

Esromiotin Molecular Weight

275.346 g/mol

Esromiotin Melting Point

105.5 oC

Esromiotin H2O Solubility

7760 mg/L

Esromiotin State


Esromiotin LogP


Esromiotin Dosage Forms


Esromiotin Indication

For the treatment of glaucoma, and in the treatment of severe anticholinergic toxicity.

Esromiotin Pharmacology

Physostigmine is a parasympathomimetic, specifically, a reversible cholinesterase inhibitor which effectively increases the concentration of acetylcholine at the sites of cholinergic transmission. Physostigmine is used to treat glaucoma. Because it crosses the blood-brain barrier, it is also used to treat the central nervous system effects of atropine overdose and other anticholinergic drug overdoses. Physostigmine can reverse both central and peripheral anticholinergia.

Esromiotin Absorption

No information avaliable

Esromiotin side effects and Toxicity

Side effects include increased sweating, loss of bladder control, muscle weakness, nausea, vomiting, diarrhea, or stomach cramps or pain, shortness of breath, tightness in chest, or wheezing, slow or irregular heartbeat, unusual tiredness or weakness, watering of mouth, blurred vision or change in near or distant vision, and eye pain.

Esromiotin Patient Information

No information avaliable

Esromiotin Organisms Affected

Humans and other mammals